ÐÓ°ÉÔ­´´

Halozyme Therapeutics logo

Halozyme Therapeutics

A biopharmaceutical company developing products to treat cancer and diabetes.

1

Funding Rounds

$63.0m

Money raised

Overview

A biopharmaceutical company developing products to treat cancer and diabetes.
  • Website:
  • Business model: B2C
  • Social accounts:

Funding series

Funding Series Analysis

The company Halozyme Therapeutics has raised a total of $63m in funding over 1 rounds.

Key Insights:

  • Halozyme Therapeutics funding round, June 2011: $63m
Halozyme Therapeutics logo
Halozyme Therapeutics funding round, June 2011 $63m